Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1071-1078
Open Access | Times Cited: 269

Showing 1-25 of 269 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 405
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Efficacy and safety of COVID-19 vaccines
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, et al.
Cochrane library (2022) Vol. 2023, Iss. 3
Open Access | Times Cited: 254
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Karen Hager, Gonzalo Pérez Marc, Philipe Gobeil, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2084-2096
Open Access | Times Cited: 173
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
Hasnat Tariq, Sannia Batool, Saaim Asif, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 144
Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
Xuejiao Han, Aqu Alu, Hongmei Liu, et al.
Bioactive Materials (2022) Vol. 17, pp. 29-48
Open Access | Times Cited: 99
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Joon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101569-101569
Open Access | Times Cited: 83
Plant-based biopharmaceutical engineering
Lukas Eidenberger, Benjamin Kogelmann, Herta Steinkellner
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 6, pp. 426-439
Open Access | Times Cited: 69
Virus-like Particle Vaccines and Platforms for Vaccine Development
Jamil Kheirvari Khezerloo, Hong Liu, Ebenezer Tumban
Viruses (2023) Vol. 15, Iss. 5, pp. 1109-1109
Open Access | Times Cited: 51
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines
Peter J. Hotez, María Elena Bottazzi
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 55-64
Closed Access | Times Cited: 86
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines
Puna Maya Maharjan, Sunghwa Choe
Vaccines (2021) Vol. 9, Iss. 9, pp. 992-992
Open Access | Times Cited: 67
“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 67
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Saranya Sridhar, Arnel Joaquin, Matthew Bonaparte, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 5, pp. 636-648
Open Access | Times Cited: 65
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective
Colin Funk, Craig A. Laferrière, Ali Ardakani
Viruses (2021) Vol. 13, Iss. 3, pp. 418-418
Open Access | Times Cited: 58
Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases
Maria Lobato‐Gómez, Xin Huang, Derry Alvarez, et al.
Plant Biotechnology Journal (2021) Vol. 19, Iss. 10, pp. 1901-1920
Open Access | Times Cited: 58
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
Matteo Castaldo, Marta Waliszewska‐Prosół, Maria Koutsokera, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 58
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
Joshua M. Royal, Carrie A. Simpson, Alison A. McCormick, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1347-1347
Open Access | Times Cited: 57
Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
Balamurugan Shanmugaraj, Christine Joy I. Bulaon, Ashwini Malla, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4032-4032
Open Access | Times Cited: 56
Role of genomics in combating COVID-19 pandemic
K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, et al.
Gene (2022) Vol. 823, pp. 146387-146387
Open Access | Times Cited: 52
A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders
Farnoosh Seirafianpour, Homa Pourriyahi, Milad Gholizadeh Mesgarha, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 52
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 222-233
Open Access | Times Cited: 47
Improving Protein Quantity and Quality—The Next Level of Plant Molecular Farming
Hai Liu, Michael P. Timko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1326-1326
Open Access | Times Cited: 45
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
Ziqi Wang, Kai Cui, Ulrich Costabel, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 43
Principles of SARS-CoV-2 glycosylation
Himanshi Chawla, Elisa Fadda, Max Crispin
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102402-102402
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top